Read More Pharma Industry News How China’s lymphoma treatment landscape could evolve with HMPL-760’s registrational study Can HMPL-760 reshape lymphoma treatment? Explore HUTCHMED’s Phase III strategy and what it means for BTK competition. bySoujanya RaviMarch 25, 2026